FR1043M - Quinazolone derivative and its salts, used in therapy. - Google Patents

Quinazolone derivative and its salts, used in therapy.

Info

Publication number
FR1043M
FR1043M FR848183A FR848183A FR1043M FR 1043 M FR1043 M FR 1043M FR 848183 A FR848183 A FR 848183A FR 848183 A FR848183 A FR 848183A FR 1043 M FR1043 M FR 1043M
Authority
FR
France
Prior art keywords
therapy
salts
quinazolone derivative
quinazolone
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR848183A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Original Assignee
Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA filed Critical Societe Industrielle pour la Fabrication des Antibiotiques SA SIFA
Priority to FR848183A priority Critical patent/FR1043M/en
Priority to GB4504261A priority patent/GB931019A/en
Priority to BE611980A priority patent/BE611980A/en
Application granted granted Critical
Publication of FR1043M publication Critical patent/FR1043M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
FR848183A 1960-12-28 1960-12-28 Quinazolone derivative and its salts, used in therapy. Expired FR1043M (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR848183A FR1043M (en) 1960-12-28 1960-12-28 Quinazolone derivative and its salts, used in therapy.
GB4504261A GB931019A (en) 1960-12-28 1961-12-15 Pharmaceutical compositions containing quinazolone compounds
BE611980A BE611980A (en) 1960-12-28 1961-12-27 Quinazolone derivative and its salts, used in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR848183A FR1043M (en) 1960-12-28 1960-12-28 Quinazolone derivative and its salts, used in therapy.

Publications (1)

Publication Number Publication Date
FR1043M true FR1043M (en) 1962-02-09

Family

ID=8745635

Family Applications (1)

Application Number Title Priority Date Filing Date
FR848183A Expired FR1043M (en) 1960-12-28 1960-12-28 Quinazolone derivative and its salts, used in therapy.

Country Status (3)

Country Link
BE (1) BE611980A (en)
FR (1) FR1043M (en)
GB (1) GB931019A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738844A1 (en) * 1987-11-16 1989-05-24 Merck Patent Gmbh ANALGESIC

Also Published As

Publication number Publication date
BE611980A (en) 1962-06-27
GB931019A (en) 1963-07-10

Similar Documents

Publication Publication Date Title
DK129687B (en) Irradiation systems for deep-acting therapy.
FR3548M (en) Substituted thioxanthenesulfonamides, and their addition salts with acids.
FR1761M (en) New pyridine, usable in therapy, in particular as an antimycotic and disinfectant.
FR3380M (en) New anthelmintic preparations, usable in therapy.
FR1043M (en) Quinazolone derivative and its salts, used in therapy.
FR1845M (en) New dihydrodibenzoxazepines and their acid addition salts.
BE602155A (en) Irradiation capsule.
BE595038A (en) Indole derivatives and their salts.
FR1181M (en) New 3-phenyl-pyrrolidines and their salts.
FR1898M (en) New substance usable in therapy.
FR1602M (en) γ-morpholinobutyrophenone and its salts.
FR1291535A (en) New quinazolines, in particular 2-guanidinoquinazolines, and their salts
BE596272A (en) New substance usable in therapy.
FR2119M (en) Allyl-4-phenyl-4-carbopropoxypiperidine, and its acid addition salts.
FR295M (en) Benzoylthiamine O-monophosphate and its salts.
FR2056M (en) 1-Cyclohexyl-2-aminopropanone- (1) and its salts.
FR1847M (en) New dihydrodibenzoxazepines and their salts.
FR79644E (en) New quinazolines, in particular 2-guanidinoquinazolines and their salts
FR1494M (en) New creation in therapy.
FR3860M (en) Halogenophenoxyacetic acids and their salts.
FR2950M (en) New octapeptide of the formula l - β - asparagyl - l - arginyl - l - valyl - l - tyrosyl - l - valyl - l - histidyl - l - prolyl - l - phenylalanine and its salts which can be used in therapy.
BE600503A (en) Butane-2,3-diols and their salts
FR2233M (en) Calcium composition usable in therapy and diet.
FR1013M (en) Analgesic, antithermic and antirheumatic drug.
FR1033M (en) New penicillin and its non-toxic salts.